Biotechnology News

← Back to All News

Some humans will live forever as we rename our company Immortals: Bryan Johnson says
A 48-year-old millionaire just told the internet he plans to never die. And he's not joking. **Bryan Johnson** — the guy who's spent millions swapping blood with his teenage son and tracking every c...
June 25, 2026•Bryan JohnsonLongevityAnti-aging
We seek to empower biotech entrepreneurs with the Samsung Bioepis Innovation Prize: Samsung Bioepis Vice President
A biotech founder in Singapore wakes up today with a very different inbox. Because **Samsung** just opened a door most early-stage scientists only dream about. Not a grant. Not a vague *"let's ta...
June 25, 2026•biotech innovationSamsung BioepisATLATL Innovation Center
Coherence Neuro tests brain implant on 3 patients to treat aggressive glioblastoma, company confirms
Imagine a brain implant that doesn't just *read* your thoughts… but hunts your cancer. That's not sci-fi anymore. It just happened in three real human patients. --- ## 🧠 Meet SOMA — ...
June 24, 2026•Brain implantCancer treatmentNeurotechnology
Anagenxyz Unveils Novel Hair Loss Treatments, Repurposing T3 and Advancing Topical Dutasteride
Anagenxyz, a telehealth platform specializing in hair growth, has announced significant advancements in its treatment offerings, including the repurposing of Liothyronine (T3) for hair loss and the la...
June 19, 2026•telehealth platformhair growthhair loss treatment
Pakistan Genome Resource Unveils 173,303 Exomes and Genomes, Illuminating Human Knockouts for Drug Discovery
A groundbreaking analysis of 173,303 exomes and genomes from the Pakistan Genome Resource (PGR) has been published in Nature, revealing a wealth of insights into human genetics and its implications fo...
June 18, 2026•Pakistan Genome Resourcehuman geneticsdrug development
Russia Commits $26 Billion to Longevity Initiative, Explores Organ Harvesting from Mini-Pigs
Moscow – Russia has launched a state-backed longevity initiative, "New Health Preservation Technologies," allocating an estimated $26 billion to research aimed at extending human life and potentially ...
June 9, 2026•Russia longevity initiativeNew Health Preservation Technologieshuman life extension
AstraZeneca CFO Affirms Progress Towards $80 Billion 2030 Revenue Goal Following Historic NYSE Listing
New York – AstraZeneca CFO Aradhana Sarin affirmed the company's steady progress towards its ambitious 2030 targets for medicines and revenue during an interview on NYSE Live. The discussion took plac...
June 6, 2026•AstraZenecabiopharmaceuticalNYSE direct listing
Tech Titans Channel Over $10 Billion into Biology and Longevity, Redefining Aging as an Engineering Challenge
A recent social media post has highlighted a significant trend: prominent figures from the digital technology sector are increasingly directing their vast resources towards biological research and lon...
June 5, 2026•digital technologybiological researchlongevity science
Longevity Biotech NewLimit Reaches $3.1 Billion Valuation Ahead of Human Trials
NewLimit, a longevity biotechnology company co-founded by Coinbase CEO Brian Armstrong, has seen its valuation surge to $3.1 billion following a substantial $435 million Series C funding round. This s...
June 4, 2026•longevity biotechnologyage-reversal researchepigenetic reprogramming
AI in Drug Discovery Market Projected to Reach $6.89 Billion by 2029 as Decoding Bio Summit Gathers Industry Leaders
New York – The Artificial Intelligence (AI) in drug discovery market is projected to surge to **$6.89 billion by 2029** from $1.86 billion in 2024, demonstrating a robust compound annual growth rate (...
June 3, 2026•AI in drug discoverydrug developmentpharmaceutical research
ARK Invest Analyst Highlights Immense Opportunity in Healthy Human Life Extension
ARK Invest, a prominent investment management firm known for its focus on disruptive innovation, is drawing attention to the significant economic and societal potential within the field of healthy hum...
June 2, 2026•healthy human life extensiondisruptive innovationmultiomics
U.S. Lawmakers Push to Add Biotechnology to COINS Act as Chinese Deals Hit $136 Billion in 2025
Influential voices are advocating for the inclusion of biotechnology in the Comprehensive Outbound Investment National Security (COINS) Act, aiming to categorize it as a strategic technology. Biotech ...
June 1, 2026•COINS Actbiotechnologynational security
Daraxonrasib Doubles Survival in Metastatic Pancreatic Cancer, Lilly's Retatrutide Shows 28% Weight Loss
Recent breakthroughs in medical science have unveiled a series of promising advancements, highlighted by Revolution Medicines' daraxonrasib, which has demonstrated an unprecedented 60% reduction in th...
June 1, 2026•Revolution MedicinesDaraxonrasibMetastatic pancreatic cancer
FDA Rejects Replimune's Melanoma Drug RP1 Twice Due to Study Design
The U.S. Food and Drug Administration (FDA) has twice rejected Replimune Group Inc.'s experimental melanoma drug, RP1 (vusolimogene oderparepvec), citing significant concerns regarding its study desig...
May 30, 2026•FDA drug rejectionReplimune RP1melanoma drug
AI Revolutionizing Biotech: Sam Rodriques Highlights Accelerated Drug Discovery
Sam Rodriques, CEO of Edison Scientific and founder of FutureHouse, recently appeared on a podcast, noting a significant shift in the application of Artificial Intelligence (AI) within the biotech and...
May 28, 2026•AI in biotechdrug discoveryscientific research automation
Eli Lilly Collaboration Advances Single-Dose Gene Therapy Targeting Permanent LDL Reduction
Eli Lilly is making strides in the development of a potentially transformative gene therapy aimed at permanently reducing LDL cholesterol, a key factor in heart disease. Recent discussions on social m...
May 26, 2026•gene therapyLDL cholesterolheart disease prevention
Elon Musk Labels Neuralink's Paralysis and Blindness Advancements 'Jesus-Level Technologies' Amidst Expanding Human Trials
Neuralink CEO Elon Musk recently described his company's brain-chip technologies, aimed at overcoming paralysis and blindness, as "Jesus-level technologies." Speaking virtually at the Samson Internati...
May 22, 2026•Neuralinkbrain-chip technologiesparalysis
Biotech M&A Surges Amid Patent Cliffs and Strategic Investments, Diverging from Everlane's Complex Retail Deal
Recent market activity indicates a significant surge in mergers and acquisitions within the biopharma sector, a trend that could see increasing private equity involvement, as speculated by Pearl Freie...
May 19, 2026•biopharma M&Aprivate equitypatent cliff
Rare Disease Parent Founders Drive Biotech Innovation with "Impatient Capital," Valuing PRVs at Up to $200 Million
Rare disease parent founders are revolutionizing biotech drug development by embracing "impatient capital" and leveraging the profit motive to accelerate therapies for ultra-rare conditions. This appr...
May 18, 2026•Rare disease drug developmentImpatient capitalBiotech entrepreneurship
Neuralink's PRIME Study Reaches 21 Participants, Enabling Paralyzed Individuals to Control Devices and Create Art
Neuralink's pioneering PRIME Study has expanded to include 21 participants worldwide as of January 2026, marking a significant advancement in brain-computer interface (BCI) technology. Among these ind...
May 16, 2026•NeuralinkBrain-Computer Interface (BCI)PRIME Study
Wedbush Maintains $12 Price Target for Intellia Therapeutics Amid ATTR-CM Trial Timeline Concerns
Wedbush has reiterated a "Neutral" rating and a $12 price target for Intellia Therapeutics (NASDAQ: NTLA), citing potential impacts on the commercial window for its Transthyretin Amyloidosis with Card...
May 14, 2026•Intellia TherapeuticsCRISPR/Cas9Gene therapy
Forus Secures $160 Million to Bridge Gap Between Drug Discovery and Patient Treatment
A newly introduced entity, Forus, has announced a substantial $160 million funding round dedicated to establishing a robust foundation for modern medicine. The company's core mission is to accelerate ...
May 13, 2026•Forusdrug discoverymedical innovation
Device Prevents Ice Formation in Pig Kidney in Under a Minute with Minimal Power
A significant advancement in organ preservation technology has been reported, showcasing a novel device capable of rapidly navigating the critical ice formation danger zone in biological tissue. The b...
May 13, 2026•organ preservationcryopreservationice formation
Call for a "3Blue1Brown for Biology" Highlights Visualization Challenges
Niko McCarty, a prominent science communicator and founding editor of Asimov Press, has sparked a discussion on social media regarding the absence of a highly visual, explanatory YouTube channel for b...
May 10, 2026•Niko McCartyscience communicationbiology visualization
First Human Trial for Partial Reprogramming Gene Therapy Cleared by FDA in 2026
The U.S. Food and Drug Administration (FDA) has cleared the first human trial for a gene therapy aimed at reversing age-related molecular damage, according to a social media post by Avi Roy. The thera...
May 10, 2026•gene therapyage reversalER-100
AI-Discovered Drugs Face 'Very Difficult' Path to Market, Syntheia CEO Notes
Katrina Choe, Co-Founder and CEO of AI drug discovery firm Syntheia, recently highlighted the significant hurdles in translating artificial intelligence advancements into approved pharmaceutical produ...
May 5, 2026•AI drug discoverySyntheiaKatrina Choe
InnovateX Secures $50 Million Series B to Advance AI Drug Discovery
An AI-driven biotech startup, InnovateX, has successfully closed a $50 million Series B funding round, according to an announcement made on social media by J.D. Haltigan, PhD, on May 3, 2026. The subs...
May 3, 2026•AI-driven biotech startupSeries B fundingdrug discovery platform
Living Carbon Secures $500M from Octopus Energy Generation to Scale Carbon-Removing Reforestation in U.S.
Living Carbon, a biotechnology company focused on developing photosynthesis-enhanced trees, has secured a significant $500 million investment from Octopus Energy Generation. This substantial funding i...
April 30, 2026•Living Carbonbiotechnologycarbon removal
MIT Engineers Develop Injectable 'Mini Livers' as Alternative for Over 10,000 Transplant Patients
MIT engineers have developed "mini livers" designed to be injected into the body, offering a potential lifeline for thousands of patients awaiting liver transplants or those too ill for surgery. As an...
April 26, 2026•mini liversliver transplant alternativeorgan scarcity solutions
PCR Speed Nears Optimal Limits Despite Innovations, Analyst Suggests
Despite ongoing efforts to accelerate Polymerase Chain Reaction (PCR) technology, including the development of light-controlled devices, the fundamental process is approaching its inherent speed limit...
April 22, 2026•Polymerase Chain ReactionPCR technologyNiko McCarty
BioMarin Finalizes $4.8 Billion Acquisition of Amicus Therapeutics, Bolstering Rare Disease Portfolio
BioMarin Pharmaceutical Inc. has completed its acquisition of Amicus Therapeutics in an all-cash transaction valued at approximately $4.8 billion. The deal, which was announced in December 2025, signi...
April 21, 2026•BioMarin PharmaceuticalAmicus Therapeuticsrare disease
Biotech Startups Pursue "Brainless Clones" for Organ Supply, Sparking Ethical Debate
A groundbreaking and ethically charged development in biotechnology has emerged, with two stealth startups, R3 Bio and Kind Biotechnology, reportedly advancing research into creating "nonsentient" bod...
April 21, 2026•biotechnologyorgan transplantationbioethics
AI Agents Uncover 30x Melanoma Predisposition in Personalized Genomic Analysis, Costing Under $100
Stripe CEO Patrick Collison recently highlighted a significant personal health discovery made through AI-powered genomic analysis, revealing a 30-fold higher-than-average predisposition to melanoma. T...
April 18, 2026•AI-powered genomic analysispersonalized preventative medicinePatrick Collison
EMF-Inducible Gene Switch Reverses Aging Phenotypes and Offers Broad Therapeutic Potential
A research group from Seoul has unveiled a groundbreaking electromagnetic field (EMF)-inducible gene switch, presenting a novel method for remotely controlling gene expression in living organisms. Pub...
April 16, 2026•EMF-inducible gene switchgene expression controlcytochrome b5 type B
Y Combinator General Partner Ankit Gupta Highlights Key Metrics for Bio-Founders' Success
Y Combinator General Partner Ankit Gupta has outlined two critical factors for bio-founders aiming to elevate their companies, emphasizing the strategic importance of data generation and predictable s...
April 15, 2026•Ankit GuptaY Combinatorbio-founders
Daraxonrasib Nearly Doubles Overall Survival to 13.2 Months in Metastatic Pancreatic Cancer Trial
REDWOOD CITY, Calif. – Revolution Medicines, a late-stage clinical oncology company, has announced groundbreaking positive topline results from its global, randomized Phase 3 RASOLUTE-302 clinical tri...
April 14, 2026•Revolution Medicinesdaraxonrasibpancreatic cancer treatment